A Serbian producer of food supplements based on cannabidiol (CBD) from medical hemp seeks distributors

The Serbian company, founded in 2019 by university professors, produces cannabidiol (CBD) oil-based food supplements from medical hemp in cooperation with a European Union certified producer of medical hemp from Slovenia. Recent scientific discoveries have shown that pathological diseases are accompanied by an unregulated endocannabinoid system. By modulating the endocannabinoid system and improving its tone, the application of CBD could potentially slow or even stop the progression of various diseases. The company offers full-spectrum CBD oil containing many of 120 compounds (cannabinoids) found in hemp thus far. These 120+ compounds found in a hemp plant are extracted together, without any alteration, in the process developed by the company and mixed with a carrier, olive oil from Crete, Greece. As result, they produce an entourage effect. The therapeutic properties of CBD and its effect on the endocannabinoid system have been tested by scientists and physicians around the world in particular for their anti-inflammatory and antioxidant properties. As of 2019, there was limited high-quality evidence for cannabidiol having a therapeutic neurological effect in people for example its possible anti-anxiety and anti-psychotic effects. CBD oil numerous positive properties that are increasingly used in everyday life. The use of CBD oil has become a supplement to pharmacological drugs that are increasingly being used by consumers. The company wishes to expand to foreign markets and to find new clients and business partners all around the European countries. The full-spectrum CBD oil is made of industrial hemp and has less than 0,2% of THC (Tetrahydrocannabinol), and will not have a psychoactive effect. The European hemp is cultivated in certified bio and vegan production without the use of artificial fertilizers, pesticides, or genetically modified organisms. At the moment, the company produces six products, four of which are intended for human use, and two are intended for pets (dogs, cats) and wish to find a partner who will distribute them in his market under the distribution services or commercial agency agreement.